NIH-funded research R01 grant

Mitochondrial DNA differences linked to sudden cardiac arrest risk and recovery

Official title: Human Mitochondrial Variation and Sudden Cardiac Arrest Risk and Resuscitation

Funded at Johns Hopkins University · NIH-11251647 · Data updated 2026-11-12

This research looks at whether differences in mitochondrial DNA affect a person's risk of sudden cardiac arrest and their chances of recovery after resuscitation.

More Cardiac Arrest research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 12, 2024
Project endJanuary 31, 2028
Funding year2026
Award (this year)$693,969
NIH project number5R01HL170579-03
Project IDNIH-11251647 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include people with ischemic heart disease, survivors of ventricular fibrillation or sudden cardiac arrest, and patients willing to provide blood or tissue samples and medical records.

Less likely to help

People without cardiac disease, those unwilling to provide genetic samples or medical records, or those seeking immediate clinical treatment would not directly benefit from this research.

What this research studies

From a patient's point of view, researchers will compare mitochondrial DNA amount and quality (including copy number, haplotypes, and somatic mutations called heteroplasmy) using blood or tissue samples from people who have had cardiac arrest and matched controls. They will apply a new computational tool to precisely measure mitochondrial mutations and link those findings to medical records about heart disease, ventricular fibrillation, and survival after resuscitation. The team will look for mitochondrial markers that predict who is more likely to have a sudden cardiac arrest and who is more likely to suffer severe heart or brain injury after resuscitation. Results could help guide prevention efforts or identify biological targets to improve survival and recovery.

Why it matters

Potential benefit: If successful, this work could help identify people at higher risk of sudden cardiac arrest and point to new ways to improve survival and protect the heart and brain after resuscitation.

How similar studies have gone: Previous work has shown mitochondrial DNA copy number is linked to sudden cardiac arrest risk, while combining haplotype and heteroplasmy analyses is a newer approach with promising early results.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Arking, Dan E — Johns Hopkins University
  • Study coordinator: Arking, Dan E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.